
#earnings for the week https://t.co/lObOE0dgsr $PYPL $PLTR $ABNB $DIS $DVN $TSN $BNTX $RBLX $RIVN $OXY $LCID $FSR $TWLO $JD $AFRM $NKLA $IEP $UPST $TTD $VTRS $SIX $WYNN $DISH $NVAX $SWKS $DOCN $FRPT $ENR $AXSM $MCK $U $SU $KKR $WDC $HIMS $LI $AMR $ANIP $BROS $WEN $THS $COTY… https://t.co/wuQ08MfzlG
The F.D.A expanded eligibility for #PFE and $BNTX #COVID19 booster shot for 16-and-17 year olds, approving emergency authorization of the third dose. The next step: #CDC formal recommendation. Pfizer #stock trading to the upside in the #market. https://t.co/3jaBa7RG3D https://t.co/SXvv4NHEOv
It might be #BlackFriday, but the biggest mover is #MRNA - up more than 20% after reports of a new COVID variant. $BNTX says it will know in the next two weeks if its vaccine will hold up, that stock is up nearly 19% and $PFE up more than 6%. https://t.co/bgV691oVXX https://t.co/WqsrHNRY7L
22.15BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US09075V1026
CUSIP
09075V102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.05
Book Value
79.41
Dividend Share
-
Dividend Yield
-
Earnings Share
-7.77
Wall Street Target Price
116.92
EPS Estimate Current Year
-4.68
EPS Estimate Next Year
-4.81
EPS Estimate Current Quarter
-2.0787
EPS Estimate Next Quarter
0.657
Most Recent Quarter
-
Revenue TTM
2,649,999,872
Gross Profit TTM
2,030,499,968
EBITDA
-1,380,800,000
Profit Margin
-63.64%
Return On Assets TTM
-5.41%
Return On Equity TTM
-9.30%
Revenue Per Share TTM
10.691
Qtly Revenue Growth YOY
-59.50%
Diluted Eps TTM
-7.77
Qtly Earnings Growth YOY
-43.20%
Trailing PE
0.00
Forward PE
7
Price Sales TTM
8.2973
Price Book MRQ
1.1181
Enterprise Value Revenue
2
Enterprise Value EBITDA
110
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%Curated watchlists where BNTX is featured.